Original assessment ยท live

WTS: Hold

Published 16 Sep 2026, 16:38 BST. This is the frozen version, not the current recommendation.

Target$343.11
Target date2027-09-15
Price known at publication$356.022026-09-11

Why this assessment was issued

Stored financial statements changed; the revised figures need checking. The model version changed. The published model version has been replaced. Record the new calculation basis even if the rating is unchanged. Neither a positive nor a negative classification meets the stated requirements. Review price and return, downside balance.

Neither a positive nor a negative classification meets the stated requirements. Review price and return, downside balance.

Supporting evidence

Year-to-date profit has improved

Across 2 completed quarters since 2025-12-31, net income was 217.9m versus 174.9m in the matching prior-year periods (USD). Check whether the latest quarter changes that direction.

Borrowing is lower relative to earnings

Net debt / EBITDA: -0.4ร— for WTS, against 1.7ร— across 12 comparable peers.

Opposing evidence

Capital spending changes the cash picture

Operating cash covers 1.04 times profit, but cash after capital spending covers 0.91 times. Cash generation is stronger before the investment bill is paid.

The profit margin narrowed

The latest quarterly operating margin was 20.2%, -0.8 percentage points from a year earlier. Compare the sales and margin contributions below.

The original scenarios

ScenarioSales growthProfit marginModel value
Weaker12.1%12.2%$263.63
Central17.1%13.5%$343.11
Stronger22.1%14.9%$436.70

Method: Earnings and historical valuation. A sufficiently complete, positive earnings record allows the stock's own P/E history to be used. These scenarios are not probability intervals.

Original assumptions and checks
eps11.82
cash347900000.0
debt108000000.0
years1.2101300479123889
growth17.11906191617277
margin14.335337840361559
profit383800000.0
cash_okTrue
debt_okTrue
growths[12.527593818984538, 15.673575129533667, 21.37992831541218, 18.564548702811877]
revenue2677300000.0
downside25.952122572704496
leverage-0.41918574174384066
multiple25.38227848101266
free_cash349400000.0
buy_hurdle15
volatility23.212046038452687
history_end2026-09-11
reward_risk0.0
annual_years5
usable_weeks157
history_start2023-09-15
history_weeks157
financial_date2026-06-30
interest_cover50.205882352941174
operating_cash397900000.0
uncapped_growth17.11906191617277
current_multiple30.120135363790183
projected_margin13.540766230884472
historical_margin12.746194621407383

Recent price ยท Passed. Weekly close dated 2026-09-11.

Suitable business model ยท Passed. Value operating cash flow or comparable earnings; deduct debt and other ownership claims where appropriate.

Four quarters ยท Passed. Four quarters ending 2026-06-30.

Current financials ยท Passed. Statements through 2026-06-30; factor prices dated 2026-09-11.

Annual record ยท Passed. 5 consecutive annual profit margins, including loss years.

Comparable earnings history ยท Passed. P/E is usable in 157 of 157 weeks. At least 52 usable weeks and 70% coverage are required; excluding too many loss or missing weeks would bias the target.

Earnings and price dates ยท Passed. Earnings-release EPS $11.82, for four quarters ending 2026-06-30.

Price risk ยท Passed. Risk uses the latest 52 weekly price changes.

Comparable sales growth ยท Passed. Growth uses the median of four quarterly year-on-year comparisons.

Positive statement earnings ยท Passed. Trailing statement profit is positive.

Earnings reconciliation ยท Passed. Release EPS is $11.82; statement-derived EPS is $11.50. The difference is within the 5% review threshold; this does not prove there are no unusual items.

Statement totals ยท Passed. The latest four quarters agree with the trailing snapshot within 5%.

Cash and borrowing ยท Passed. Cash generation, debt and interest-cover figures are available.

Target publication review ยท Passed. The model estimate is within SM's automatic publication range of one quarter to four times the current price. This is a review threshold, not evidence that the market price is correct.

Policy sm-review-2-research ยท Model sm-assessment-14-operating-capital ยท Data a1fe0278b8d1.

Open current research โ†—

Evidence context